Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
allosteric modulators
Biotech
Gain's phase 1 win paves way to prove Parkinson's drug's worth
Gain aims to prove the efficacy of its Parkinson’s therapy next year after the brain-penetrant molecule demonstrated “peripheral target engagement.”
James Waldron
Aug 29, 2024 10:05am
AbbVie connects with HotSpot for $40M cash
Dec 6, 2022 10:50am
Atavistik Bio snags $60M to tackle metabolic diseases, cancers
Aug 24, 2021 5:23pm
Nimbus vets launch allosteric drugmaker HotSpot with $45M
Jul 17, 2018 9:51am
Appello raises $10.5M for new Vanderbilt Parkinson’s drug
Jun 28, 2018 10:40am
Opioid alternative relieves pain without dependency in mice
Oct 26, 2017 8:40am
